Insurer Humana can advance antitrust claims over Mallinckrodt’s decision to spike the price of Acthar, which treats infantile spasms and multiple sclerosis, by a factor of 1,000, a federal judge in Los Angeles ruled.
Mallinckrodt offered “a number” of arguments against the economic analysis by Humana’s expert. But “these criticisms appear better directed to a challenge at the summary judgment stage,” Judge Dale S. Fischer wrote August 14. Humana’s claims “need only be plausible,” not “proven,” the judge said.
When the lawsuit was filed, Mallinckrodt told Becker’s in a statement that it “strongly believes that Humana’s complaint is completely without merit” and “that the complaint should be dismissed in its entirety.”
Federal Judge Dale Fischer of Los Angeles declined to grant Mallinckrodt’s motion to dismiss the lawsuit in its entirety, though granted dismissal of some parts of the suit. According to his August 14 order, Mr. Fischer said Humana’s antitrust claims against Mallinckrodt can advance.
Full Content: Bloomberg
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
ConocoPhillips Acquires Marathon Oil for $22.5 Billion in Major Energy Sector Consolidation
May 29, 2024 by
CPI
Judge Denies Amazon’s Bid to Dismiss FTC Lawsuit Over Prime Membership Practices
May 29, 2024 by
CPI
Germany and France Advocate for Major EU Competition Reform
May 29, 2024 by
CPI
Equifax Accused of Monopolizing Employment Verification Market in New Suit
May 29, 2024 by
CPI
Car Battery Makers to Challenge EU Cartel Charges in Brussels
May 29, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Merger Guidelines Retrospective
May 21, 2024 by
CPI
Mergers of Complements
May 21, 2024 by
CPI
Personality Traits, Private Equity, and Merger Analysis
May 21, 2024 by
CPI
The 2023 Merger Guidelines: Lessons in the Importance of Incipiency, Modern Economics, and Monopsony
May 21, 2024 by
CPI
The 2023 Merger Guidelines: Sharpening Merger Analysis
May 21, 2024 by
CPI